These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 16616645
1. Role of inducible costimulator in the development of lupus in MRL/lpr mice. Tada Y, Koarada S, Tomiyoshi Y, Morito F, Mitamura M, Haruta Y, Ohta A, Nagasawa K. Clin Immunol; 2006 Aug; 120(2):179-88. PubMed ID: 16616645 [Abstract] [Full Text] [Related]
2. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice. Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW. J Immunol; 1999 Sep 15; 163(6):3153-9. PubMed ID: 10477582 [Abstract] [Full Text] [Related]
3. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus. Zeller GC, Hirahashi J, Schwarting A, Sharpe AH, Kelley VR. J Am Soc Nephrol; 2006 Jan 15; 17(1):122-30. PubMed ID: 16291836 [Abstract] [Full Text] [Related]
4. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B. J Am Soc Nephrol; 2005 Dec 15; 16(12):3592-601. PubMed ID: 16267157 [Abstract] [Full Text] [Related]
5. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. Wenderfer SE, Ke B, Hollmann TJ, Wetsel RA, Lan HY, Braun MC. J Am Soc Nephrol; 2005 Dec 15; 16(12):3572-82. PubMed ID: 16207826 [Abstract] [Full Text] [Related]
6. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice. Fujii T, Okada M, Fujita Y, Sato T, Tanaka M, Usui T, Umehara H, Mimori T. J Autoimmun; 2009 Sep 15; 33(2):125-34. PubMed ID: 19596182 [Abstract] [Full Text] [Related]
7. Role for inducible costimulator in control of Salmonella enterica serovar Typhimurium infection in mice. Vidric M, Bladt AT, Dianzani U, Watts TH. Infect Immun; 2006 Feb 15; 74(2):1050-61. PubMed ID: 16428752 [Abstract] [Full Text] [Related]
9. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. Liang B, Gee RJ, Kashgarian MJ, Sharpe AH, Mamula MJ. J Immunol; 1999 Aug 15; 163(4):2322-9. PubMed ID: 10438978 [Abstract] [Full Text] [Related]
10. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T, Sugiyama N, Niiro H, Harada M. Arthritis Rheum; 2007 May 15; 56(5):1618-28. PubMed ID: 17469144 [Abstract] [Full Text] [Related]
11. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'. Rojo JM, Pini E, Ojeda G, Bello R, Dong C, Flavell RA, Dianzani U, Portolés P. Int Immunol; 2008 Apr 15; 20(4):577-89. PubMed ID: 18310064 [Abstract] [Full Text] [Related]
12. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U. J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217 [Abstract] [Full Text] [Related]
13. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells. Tago F, Tsukimoto M, Nakatsukasa H, Kojima S. Radiat Res; 2008 Jan 01; 169(1):59-66. PubMed ID: 18159952 [Abstract] [Full Text] [Related]
14. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K. Arthritis Rheum; 2011 Mar 01; 63(3):738-48. PubMed ID: 21305501 [Abstract] [Full Text] [Related]
15. Lack of association of V beta 8+ T cells with lupus-like syndrome in MRL-lpr/lpr mice. Fossati L, Merino R, Iwamoto M, Lemoine R, Izui S. Eur J Immunol; 1994 Jul 01; 24(7):1717-20. PubMed ID: 8026533 [Abstract] [Full Text] [Related]
16. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus. Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q. Rheumatology (Oxford); 2005 Oct 01; 44(10):1245-54. PubMed ID: 15987711 [Abstract] [Full Text] [Related]
17. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Hu N, Long H, Zhao M, Yin H, Lu Q. Scand J Rheumatol; 2009 Oct 01; 38(6):464-71. PubMed ID: 19922023 [Abstract] [Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S. J Rheumatol; 2002 Apr 01; 29(4):707-16. PubMed ID: 11950011 [Abstract] [Full Text] [Related]
19. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice. Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T. Arthritis Rheum; 2003 Feb 01; 48(2):486-94. PubMed ID: 12571859 [Abstract] [Full Text] [Related]
20. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. Chan O, Shlomchik MJ. J Immunol; 1998 Jan 01; 160(1):51-9. PubMed ID: 9551955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]